2021-12-01

All about stem cell therapy for AIDS

In recent years, clinical studies exploring the use of mesenchymal stem cells to treat AIDS have been steadily advancing, and the number of research findings being published is also growing. We believe that in the future, more HIV/AIDS patients will benefit from this innovative approach.

+

2021-11-26

The "Ethical Assessment Guidelines for Stem Cell Sources," co-drafted by Jiuzhitang Maker, has been officially released.

Jiuzhitang Maker was invited as one of the drafting organizations, with Chairman Zhang Quancheng and General Manager Gao Yansong participating in the drafting process.

+

2021-11-25

Let's strive to achieve a batch of groundbreaking, original breakthroughs in areas like stem cell therapy and regenerative medicine! Beijing has released the "Beijing Plan for Building an International Science and Technology Innovation Center during the 14th Five-Year Period."

Let's strive to achieve a batch of groundbreaking, original breakthroughs in areas like stem cell therapy and regenerative medicine! Beijing has released the "Beijing Plan for Building an International Science and Technology Innovation Center during the 14th Five-Year Period."

+

2021-11-22

The "Tianjin Municipal Biopharmaceutical Industry Development Special Plan for the 14th Five-Year Period" has been released, with a focus on building the Bincheng Biopharmaceutical Industry Cluster Core Area.

Develop specialized service platforms for gene therapy, cell therapy, immunotherapy, and other cutting-edge treatments that align with international standards, accelerating the translation and adoption of innovative therapeutic technologies.

+

2021-11-19

What lesson does the passing of Yang Junyong, who played Jia Rong in the 1987 version of "Dream of the Red Chamber," remind us of?

Recently, Yang Junyong, the actor who portrayed Jia Rong in the 1987 TV adaptation of "Dream of the Red Chamber," passed away unexpectedly at the age of 57 due to a sudden heart attack. His untimely departure has left many feeling deeply saddened—and serves as a stark reminder that autumn and winter are peak seasons for cardiovascular diseases, making it especially crucial to remain vigilant against the risk of acute myocardial infarction.

+

2021-11-15

The Shenzhen Municipal People's Congress Standing Committee has officially released the "Shenzhen Special Economic Zone Regulations on Promoting the Cell and Gene Industry (Draft for Comments)."

The draft regulations (for public consultation) standardize the collection and storage of cells, provide specific guidelines for expanded clinical trial systems involving cell and gene therapies, and encourage the development and application of gene technology research.

+

2021-11-09

Messi recently underwent stem cell therapy in Madrid.

During the previous match between Paris Saint-Germain and Lille, Messi was substituted by teammate Icardi in the second half due to an injury. After the game, PSG officially announced that Messi is experiencing discomfort in his left hamstring and pain in his knee. As a result, Messi has chosen to undergo stem-cell therapy in Madrid, focusing on rehabilitating damaged tendons, muscles, and other affected tissues to facilitate full recovery.

+

2021-10-20

"The 'Most Influential List in China's Pharmaceutical Industry' Officially Released—Li Zhenguo, Chairman of Jiuzhitang, Honored as One of China's Top 10 Leaders in the Pharmaceutical Sector"

Jiuzhitang has been honored as a "Pioneer of Independent Innovation in China's Pharmaceutical Industry (50) – Private Enterprises," a "Top 100 Chinese Pharmaceutical Manufacturing Companies," and one of the "Top 50 Chinese Chain Drugstore Enterprises." Meanwhile, Li Zhenguo, Chairman of Jiuzhitang Co., Ltd. and President of Jiuzhitang Group, has earned the prestigious title of "One of China's Top 10 Leaders in the Pharmaceutical Industry."

+

2021-10-12

Once again recognized—Jiuzhitang Maker proudly earns the 2021 China Biopharmaceutical Company with Greatest Growth Potential Award.

This year, we’ve once again made the list, earning the "2021 China Biopharmaceutical Company with the Greatest Growth Potential Award"—a testament to and recognition of our company’s remarkable breakthroughs and strong capabilities in the stem-cell field, as acknowledged by industry media and experts.

+
< 1...131415...31 >